Concomitant Administration of Lumiracoxib and a Triphasic Oral Contraceptive Does Not Affect Contraceptive Activity or Pharmacokinetic Profile-Reference-Cited by-同舟云学术

Concomitant Administration of Lumiracoxib and a Triphasic Oral Contraceptive Does Not Affect Contraceptive Activity or Pharmacokinetic Profile

Published:2004-06 Issue:6 Volume:44 Page:646-654
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Kalbag Jyoti,Elder Cheryl,Scott Graham,Wang Yibin,Milosavljev Slavica,Leese Philipp,Caldwell Jacque,Rordorf Christiane

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. The coxibs, selective inhibitors of cyclooxygenase-2;FitzGerald;N Engl J Med,2001

2. Celecoxib is associated with a significantly lower incidence of clinically significant upper gastrointestinal events in osteoarthritis and rheumatoid arthritis patients as compared to NSAIDs [abstract];Goldstein;Gastroenterology,1999

3. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs;Langman;JAMA,1999

4. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin;Sigthorsson;Gut,2000

5. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial;Simon;JAMA,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lumiracoxib in the management of osteoarthritis and acute pain;Expert Opinion on Pharmacotherapy;2007-07

2. Lumiracoxib;Drugs of Today;2007

3. Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor;Expert Opinion on Investigational Drugs;2005-04

4. Clinical Pharmacology of Lumiracoxib;Clinical Pharmacokinetics;2005

5. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2004-10-19